Opportunistic screening for type 2 diabetes in community pharmacies. Results from a region-wide experience in Italy

PLoS One. 2020 Mar 18;15(3):e0229842. doi: 10.1371/journal.pone.0229842. eCollection 2020.

Abstract

Background and aims: Given the paucity of symptoms in the early stages of type 2 diabetes, its diagnosis is often made when complications have already arisen. Although systematic population-based screening is not recommended, there is room to experience new strategies for improving early diagnosis of the disease in high risk subjects. We report the results of an opportunistic screening for diabetes, implemented in the setting of community pharmacies.

Methods and results: To identify people at high risk to develop diabetes, pharmacists were trained to administer FINDRISC questionnaire to overweight, diabetes-free customers aged 45 or more. Each interviewee was followed for 365 days, searching in the administrative database whether he/she had a glycaemic or HbA1c test, or a diabetologists consultation, and to detect any new diagnosis of diabetes defined by either a prescription of any anti-hyperglycaemic drug, or the enrolment in the register of patients, or a hospital discharge with a diagnosis of diabetes. Out of 5977 interviewees, 53% were at risk of developing diabetes. An elevated FINDRISC score was associated with higher age, lower education, and living alone. Excluding the number of cases expected, based on the incidence rate of diabetes in the population, 51 new cases were identified, one every 117 interviews. FINDRISC score, being a male and living alone were significantly associated with the diagnosis.

Conclusions: The implementation of a community pharmacy-based screening programme can contribute to reduce the burden of the disease, particularly focusing on people at higher risk, such as the elderly and the socially vulnerable.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Glucose / analysis
  • Community Pharmacy Services*
  • Databases, Factual
  • Diabetes Mellitus, Type 2 / diagnosis*
  • Female
  • Humans
  • Italy
  • Male
  • Mass Screening / methods*
  • Middle Aged
  • Overweight / complications*
  • Pharmacies
  • Surveys and Questionnaires

Substances

  • Blood Glucose

Grants and funding

The study has been supported by a financial grant from the Italian Ministry of Health, and an unconditional grant from Federfarma Piemonte. Federfarma is a syndicate (representative of pharmacists), not a company with commercial purposes. Federfarma only provided financial support in the form of research materials (such as questionnaires), and did not have any additional role in the management of the study.